Legal Representation
Attorney
David Toren
USPTO Deadlines
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 6, 2006 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 9, 2005 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Feb 9, 2005 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Aug 19, 2004 | CFIT | O | CASE FILE IN TICRS | Loading... |
| Mar 22, 2004 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 15, 2004 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 15, 2004 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 7, 2003 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jul 15, 2003 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 25, 2003 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Apr 25, 2003 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 26, 2003 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
| Mar 26, 2003 | EXPI | T | EX PARTE APPEAL-INSTITUTED | Loading... |
| Mar 17, 2003 | EXAF | T | EXPARTE APPEAL RECEIVED AT TTAB | Loading... |
| Mar 5, 2003 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 24, 2003 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 18, 2002 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 17, 2002 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 6, 2002 | CNFR | O | FINAL REFUSAL MAILED | Loading... |
| Oct 9, 2001 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 12, 2001 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Mar 29, 2001 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 28, 2001 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for use in the treatment of illnesses and diseases affecting the central nervous system, the peripheral nervous system, sensory organs, respiratory organs, and digestive organs; allergy medications; cardiovascular pharmaceuticals; hormones for medical purposes; urogenital and anal treatment pharmaceuticals; dermatological preparations; vitamins; nutritional supplements and dietary supplements containing amino acid preparations for medical use; nutritional supplements and dietary supplements containing calcium; nutritional supplements and dietary supplements containing chondroitin preparations; nutritional supplements and dietary supplements containing proteins, amino acids, saccharide, minerals, pharmaceutical preparations for blood, namely anticoagulants, blood substitutes for human use and blood-plasma; pharmaceutical preparations for treatment of metabolic conditions; tumor suppressing pharmaceuticals; pharmaceutical preparations for treating physically caused skin lesions; pharmaceutical preparations for treating chemically caused skin lesions; antibiotic preparations; chemotherapeutic pharmaceuticals; biological preparations namely clinical reagents for medical purposes comprising antibacterial sera, antitoxins, toxoids, toxins and vaccines; parasiticides for domestic, agricultural and medical use; diagnostic preparations for medical laboratory use; veterinary vitamins; veterinary antibiotic preparations; veterinary biological preparations, namely clinical reagents for medical purposes; mosquito-repellent incenses; general purpose germicides; fungicides, insecticides, pesticides all for agricultural and domestic use; fumigants and herbicides all for agricultural and domestic use; room deodorants not for personal use; insect repellents; mothproofing preparations, namely moth balls; antiseptics
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005